Next generation self-replicating RNA vectors for vaccines and immunotherapies

RNA technology has recently come to the forefront of innovative medicines and is being explored for a wide range of therapies, including prophylactic and therapeutic vaccines, biotherapeutic protein expression and gene therapy. In addition to conventional mRNA platforms now approved for prophylactic...

Descripción completa

Detalles Bibliográficos
Autores principales: Aliahmad, Parinaz, Miyake-Stoner, Shigeki J., Geall, Andrew J., Wang, Nathaniel S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861484/
https://www.ncbi.nlm.nih.gov/pubmed/35194198
http://dx.doi.org/10.1038/s41417-022-00435-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861484/
https://www.ncbi.nlm.nih.gov/pubmed/35194198
http://dx.doi.org/10.1038/s41417-022-00435-8

Ejemplares similares